AVTX - CIK 0001534120
Avalo Therapeutics, Inc. has filed 997 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (412 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G/A | - | 2025-11-13 | - |
| Employee stock plan | S-8 | 2025-11-06 | - |
| Quarterly report | 10-Q | 2025-11-06 | 2025-09-30 |
| Major company event | 8-K | 2025-11-06 | 2025-11-06 |
| SCHEDULE 13G | - | 2025-10-30 | - |
| Major company event | 8-K | 2025-10-29 | 2025-10-29 |
| Major company event | 8-K | 2025-10-10 | 2025-10-10 |
| Insider trade | 4 | 2025-10-06 | 2025-10-01 |
| New insider ownership | 3 | 2025-10-06 | 2025-10-01 |
| Insider trade | 4 | 2025-10-02 | 2025-09-30 |
| Insider trade | 4 | 2025-10-02 | 2025-10-01 |
| New insider ownership | 3 | 2025-10-02 | 2025-10-01 |
| Major company event | 8-K | 2025-10-01 | 2025-09-29 |
| Major company event | 8-K | 2025-09-22 | 2025-09-16 |
| SCHEDULE 13G/A | - | 2025-08-27 | - |
| SCHEDULE 13G/A | - | 2025-08-14 | - |
| Quarterly report | 10-Q | 2025-08-07 | 2025-06-30 |
| Major company event | 8-K | 2025-08-07 | 2025-08-07 |
| SCHEDULE 13G | - | 2025-08-05 | - |
| Major company event | 8-K | 2025-06-20 | 2025-06-20 |
| Major company event | 8-K | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| Insider trade | 4 | 2025-06-18 | 2025-06-17 |
| New insider ownership | 3 | 2025-06-18 | 2025-06-17 |
| Major company event | 8-K | 2025-06-17 | 2025-06-17 |
| Major company event | 8-K | 2025-06-05 | 2025-06-03 |
| Prospectus supplement | 424B5 | 2025-06-05 | - |
| Major company event | 8-K | 2025-06-04 | 2025-06-04 |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| SCHEDULE 13G | - | 2025-05-15 | - |
| SCHEDULE 13G/A | - | 2025-05-15 | - |
| Employee stock plan | S-8 | 2025-05-12 | - |
| Employee stock plan | S-8 | 2025-05-12 | - |
| Quarterly report | 10-Q | 2025-05-12 | 2025-03-31 |
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| Major company event | 8-K | 2025-05-08 | 2025-05-08 |
| Annual report to shareholders | ARS | 2025-05-01 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-05-01 | - |
| Proxy statement | DEF 14A | 2025-05-01 | 2025-06-17 |
| Insider trade | 4 | 2025-04-01 | 2025-03-28 |
| Insider trade | 4 | 2025-04-01 | 2025-03-28 |
| Insider trade | 4 | 2025-04-01 | 2025-03-28 |
| Insider trade | 4 | 2025-04-01 | 2025-03-28 |
| Insider trade | 4 | 2025-04-01 | 2025-03-28 |